CEACAM5 and cholangiocarcinoma: Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) have been used as serum biomarkers for routine screening for CCA, but their sensitivity and specificity are not satisfactory.